Architect Bnp Assay, Model 8K28
Test, Natriuretic Peptide. 510(k) K060964, from Fujirebio Diagnostics,Inc. (Malvern, PA). Product code NBC, class 2.
As of Nov 19, 2026, K060964 is an FDA 510(k) held by Fujirebio Diagnostics,Inc., substantially equivalent on May 25, 2006 after 48 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 48 days
- Recalls: 2
ARCHITECT BNP Reagent Kit The ARCHITECT BNP assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of human B-type natriuretic peptide (BNP) in human EDTA plasma on the ARCHITECT i System. BNP values are used as an aid in the diagnosis and assessment of severity of heart failure.
- Abbott Axsym B-Type Natriuretic Peptide (Bnp) Microparticle Enzyme Immunoassay (Meia) TestK033606 · Axis-Shield Diagnostics, Ltd. · Jan 30, 2004
| Started | Recall | Status |
|---|---|---|
| May 24, 2019 | Z-2079-2019, Z-2078-2019Presence of a time dependent, stability drift in patient and control results returned from ARCHITECT BNP testing. | Terminated |
- Access BNP IIK262597 · Beckman Coulter, Inc. · Oct 20, 2026
- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity iK253539 · Axis-Shield Diagnostics, Ltd. · Feb 18, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- Access NT-proBNPK232164 · Beckman Coulter, Inc. · Apr 12, 2024
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 7, 2006
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files